B02*Ramucirumab as second line therapy in metastatic...

Annals of Oncology 2016 / 09 Vol. 27; Iss. suppl_4

B02*Ramucirumab as second line therapy in metastatic gastric cancer (MGC): results of the Italian compassionate-use named patients. The RAMoss study

De Vita, F., Niger, M., Vivaldi, C., Giommoni, E., Zaniboni, A., Bozzarelli, S., Tomasello, G., Sava, T., Spada, M., Menatti, E., Proserpio, I., Galdy, S., Bittoni, A., Bencardino, K., Squadroni, M.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw333.02
Date:
September, 2016
File:
PDF, 67 KB
2016
Conversion to is in progress
Conversion to is failed